Tissue Sealants report covers the sources of Sealants and the various applications of tissue sealants in the market. The Sources of Tissue Sealants covered include Homologous Sealants, Synthetic Sealants and Autologous Sealants. The applications of Tissue Sealants covered include Odontology, Cardiology, Neurology, Orthopedics and Other (such as Urology, Hepatic, and Dermatology etc.).

The report provides an in depth analysis of each of the Sources and Applications by their respective categories. The study includes estimates and projections for the total global Tissue Sealants market and also key regional markets that include North America, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Estimates and projections (169 exhibits) are illustrated graphically. A total of 119 companies are covered while business profiles of 32 major companies are discussed in the report. The report serves as a guide to global Tissue Sealants market Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions.

Free Sample Research Report

Download Table of contents

The sealing of wounds and skin openings after surgery can be done in a compact manner with the help of tapes and sutures which reduce the rate of contamination of the injured regions by waste materials and infectious organisms. The other important advantage is that the use of tapes and sutures will reduce the scar formations to some extent. The major risk with these techniques is the improper application of tapes and sutures causing complications such as infections, longer time periods of healing of wounds and in some rare cases even death because of infections in the tissue resulting in septicemia.

Global Tissue Sealants market is projected to grow at 18.9% compounded annually from 2005 through 2012. The United States, the leading market (35% of global market share in 2006) for Tissue Sealants presently is projected to manage the leading position throughout the analysis period with its share dropping to 33.25% by 2012. Due to the cost advantage and rapid increase in population, Asia-Pacific is the fastest growing (19.63% during 2005-2012) market for Tissue Sealants. Asia-Pacific and Rest of World are expected to gain market shares. The medical organizations all over the world have been persistently making efforts to manage wounds. Medical practitioners have been trying to find an impeccable remedy substance that would seal and heal human tissues and which would also be an ideal alternative to stick the tissue exteriors so that bleeding can be prevented and also provide a supportive healing platform.

The market is already occupied by devices such as biological glues and adhesives which are strong synthetic and biological materials that glue the surfaces together, preventing the wide spread use of fibrin sealants in the market. Product substitution and off label use are the areas challenging the wide spread use of fibrin sealants. Although the market is aware about the advantages of fibrin sealants in cardiothoracic and pulmonary applications, their utility in surgical applications is challenged because of insufficient clinical proof.

There will be an increasing market if there is enough documentation on the evidences collected for the use of fibrin sealants in other areas of surgical applications. The policy of companies to improve the market is to invest more in innovative products and new areas of application which expands the market opportunities.

3M Company (USA)
Abbott Laboratories (USA)
Advanced Medical Solutions Group plc (UK)
Aesculap, Inc. (USA)
Angiotech Pharmaceuticals, Inc. (Canada)
B. Braun Melsungen AG (Germany)
Baxter International, Inc. (USA)
C.R. Bard, Inc. (USA)
Confluent Surgical, Inc. (USA)
Covidien Ltd. (USA)
CryoLife, Inc. (USA)
CSL Behring (USA)
Davol, Inc. (USA)
Ethicon, Inc.
FibroGen, Inc. (USA)
Genzyme Corporation (USA)
Haemacure Corporation (Canada)
Johnson & Johnson (USA)
Kaketsuken (Japan)
Kensey Nash Corporation (USA)
King Pharmaceuticals, Inc. (USA)
Laboratoires URGO (France)
Medafor, Inc. (USA)
Nycomed International Management GmbH (Switzerland)
Olympus Terumo Biomaterials Corporation (Japan)
Omrix Biopharmaceuticals, Inc. (USA)
Pfizer, Inc. (USA)
Pharming Group NV (The Netherlands)
Protein Polymer Technologies, Inc. (USA)
Shanghai Pine & Power Biotech Co., Ltd. (China) Synovis Life Technologies, Inc. (USA)
ThermoGenesis Corporation (USA)
Vivostat A/S (Denmark)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	Provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global Tissue Sealant market, by source and applications. Global market is also analyzed by geographic regions including North America, Japan, Europe, Asia-Pacific, Latin America and Rest of World. The chapter provides market values in US$ (2005 - 2012). A List of global major companies is also provided.	$1000
III	Product / Technology Research	This chapter gives an insight into Tissue Sealants market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities.	$800
IV	Market Dynamics	Market Dynamics chapter provides information on global markets for Tissue Sealant by source and application. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both source application segment; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.	$1300
V	Corporate Directory	This chapter provides a global region-wise list of more than 100 companies that offer Tissue Sealants products and/or services.	$300